Total
0
Shares
Pro Medicus (ASX:PME) signs 5-year cloud based deal with Nines
  • Pro Medicus (PME) says its U.S. subsidiary, Visage Imaging, has signed a five-year contract with radiology company Nines
  • The contract will see Nines utilise the Visage 7 cloud-based technology for future radiology services
  • Pro Medicus is expected to earn over A$6 million in revenue during the contract term
  • Implementation will begin in the next few weeks
  • Pro Medicus is up a slight 1.45 per cent, with shares trading for $23.86 each

Pro Medicus (PME) has announced its U.S. subsidiary, Visage Imaging, has signed a five-year, multi-million dollar contract with Palo Alto-based Nines.

Nines is a radiology company that builds modern tools for optimal patient care. It aims to enable medical groups and hospitals to move beyond traditional methods and provide reliable, higher-quality service.

Nines was co-founded by CEO David Stavens PhD and Chief Medical Officer Alexander Kagen.

"Visage and Nines are collaborating on a modern cloud-based service with an eye toward exceeding those expectations," David said.

"Nines selected Visage for its tech-focused leadership and we’re excited to offer Visage 7 as part of our scalable solution," he added.

The offering, based on Visage 7 technology, will be hosted on Google Cloud and provide Nines with a highly optimised platform.

Visage 7 enables organisations to use the capabilities of what historically required multiple viewers into a single, customisable viewing platform.

The contract is based on committed exam volumes that align with the projected growth of the Nines offering. This is expected to result in over A$6 million of revenue for Pro Medicus.

Implementation is expected to begin over the next few weeks.

"This deal further validates our belief that our product can address a large percentage of the total addressable market in North America, ranging from smaller radiology partnerships through to some of the world’s largest, most sophisticated healthcare institutions," Pro Medicus CEO Dr Sam Hupert said.

"And now our partnership with Nines is the next step in developing future services for high-quality remote reading/teleradiology," Sam added.

Pro Medicus is up a slight 1.45 per cent, with shares trading for $23.86 each at 11:26 am AEDT.


Subscribe


PME by the numbers
More From The Market Herald
PolyNovo (ASX:PNV) - CEO, Paul Brennan - The Market Herald

" Polynovo (ASX:PNV) recieves US$15M in funding from BARDA

Polynovo (PNV) has received US$15 million (nearly A$22 million) from the U.S. Department of Health to support the NovoSorb BTM pivotal trial program.
TechnologyOne (ASX:TNE) - Chief Executive, Edward Chung (left) and Executive Chairman Adrian Di Marco - The Market Herald

" TechnologyOne (ASX:TNE) hits back over claims of revenue report inflation

Software company TechnologyOne (TNE) has denied allegations it has been ‘artificially improving’ its profit guidance by using ‘accounting tricks.’
Credit Corp Group (ASX:CCP) - CEO, Thomas Beregi - The Market Herald

" Credit Corp (ASX:CCP) takes $65M profit hit

Debt collector Credit Corp (CCP) has encountered a $65 million profit hit due to the COVID-19 pandemic and a purchased debt ledger (PDL)
Avita Medical (ASX:AVH) - CEO, Dr Michael Perry - The Market Herald

" Avita Therapeutics (ASX:AVH) signs US$7.6M agreement with BARDA

Regenerative medicine company Avita Therapeutics (AVH) has teamed up with Biomedical Advanced Research and Development Authority (BARDA) for its RECELL System.